Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Biomarkers and response monitoring at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

33 organizations at SITC 2026 present work in biomarkers & response monitoring: 26 suppliers and service providers, 3 cancer centres and hospitals, 2 pharma and biotech companies, 1 government or non-profit body and 1 university or research institute. Between them they bring 6 presentations to the program. Most represented: U.S. Food and Drug Administration (8 on the program), MD Anderson Cancer Center (5 on the program), Merck & Co. (2 on the program). 31 of them have their own page in this guide. As of Sep 29, 2026.

All 242 organizations at SITC 2026 →

Showing 1–14 of 33 organizations

Organization	SITC 2026 Attendance
U.S. Food and Drug Administration Silver Spring, MD
fda.gov Government & non-profit U.S. federal agency that regulates drugs, biologics and medical devices, including cancer immunotherapies.	Session Wed Nov 4 2:10pm–2:55pm Panel Discussion 1: Conversations with FDA Oncology Leaders on Hot Topics Encanto AB Regulatory Session Wed Nov 4 3:10pm–3:55pm Panel Discussion 2: Biomarker Discovery and Digital AI Encanto AB Biomarkers · AI & data Session Wed Nov 4 4:10pm–4:55pm Panel Discussion 3: Regulatory Framework for New IO Agents Encanto AB Regulatory · New agents Talk Fri Nov 6 2:45pm–3:00pm Part of Session 106b: Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip From Conventional to New Approach Methodologies: Regulatory Considerations for Immuno-Oncology Safety Assessment 301A Regulatory · Models & tech
MD Anderson Cancer Center Houston, TX
mdanderson.org Cancer centres & hospitals University of Texas comprehensive cancer center in Houston focused on cancer patient care, research and education.	Session Thu Nov 5 12:00pm–1:30pm Career Paths for Physician Scientists Encanto AB Workshop Thu Nov 5 7:00pm–8:00pm Early Career Scientist Speed Mentoring 7:00pm–8:00pmSpeed Mentoring - Group Mentoring 7:00pm–7:30pmSpeed Mentoring - One-on-One 7:30pm–8:00pmSpeed Mentoring - One-on-One 2 Talk Sat Nov 7 10:00am–10:20am Part of Session 202: Spatial Biology Spatial Biomarkers of Immunotherapy Response Halls BC Biomarkers · Models & tech Talk Sat Nov 7 3:55pm–4:15pm Part of Session 206b: IO in Low Mutation Burden Cancers From the Clinic to the Lab: Investigating Mechanisms of Response and Resistance to Immune Checkpoint Therapy Hall A Tumor biology Session Sat Nov 7 3:30pm–4:50pm Oral Abstract Session 3 301D 3:30pm–4:45pm5 abstract presentations — titles not yet released Talk Sun Nov 8 11:30am–11:45am Part of Session 303: COOPERATIVE BINDING: The bi-specific VEGF/PD(L)-1 Inhibitor Approach to cancer immunotherapy: Savior or Pretender? Biology and Clinical Results of Anti-VEGF+PD1 Bispecfics Hall A New agents
Merck & Co. Rahway, NJ
merck.com Large pharma Global pharmaceutical company, known as MSD outside the US and Canada, running a broad oncology research and clinical development program.	Booth Exhibiting at Booth 1228 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Session Wed Nov 4 3:10pm–3:55pm Panel Discussion 2: Biomarker Discovery and Digital AI Encanto AB Biomarkers · AI & data Talk Thu Nov 5 5:55pm–6:15pm Part of High-Impact Talks from Pharma Leaders Advancing External Innovation: Merck’s Oncology Strategy Regulatory Session Thu Nov 5 6:55pm–7:15pm Panel Session Fri Nov 6 3:55pm–5:30pm Biotech Session: The Next Generation of Off-the-Shelf IO Halls BC Cell therapy 3:55pm–4:10pmNext-gen T Cell Engagers 4:10pm–4:25pmIn vivo Cell Therapy Platforms for CancerEli Lilly and Company 4:25pm–4:40pmAllogeneic Cell TherapiesAllogene Therapeutics 4:40pm–5:00pm2 abstract presentations — titles not yet released 5:00pm–5:30pmIn Vivo - Ex Vivo DebateKite Pharma, Massachusetts Institute of Technology, Roswell Park Comprehensive Cancer Center, Azalea Therapeutics
Pfizer New York, NY
pfizer.com Large pharma Global pharmaceutical company with an oncology portfolio that includes antibody-drug conjugates from its Seagen acquisition.	Workshop Wed Nov 4 2:00pm–5:00pm Biotech Regulatory Roundtable 2:00pm–2:10pmOpening Remarks: SITC Biotech Initiative: A Quest for 100 Novel Agents 2:10pm–2:55pmPanel Discussion 1: Conversations with FDA Oncology Leaders on Hot Topics 2:55pm–3:10pmNetworking Break 3:10pm–3:55pmPanel Discussion 2: Biomarker Discovery and Digital AI 3:55pm–4:10pmNetworking Break #2 4:10pm–4:55pmPanel Discussion 3: Regulatory Framework for New IO Agents 4:55pm–5:00pmClosing Remarks Workshop Wed Nov 4 3:10pm–3:55pm Panel Discussion 2: Biomarker Discovery and Digital AI Encanto AB Biomarkers · AI & data
Université Paris Cité Paris, France
u-paris.fr Universities & research institutes Public research university in Paris with a large faculty of health.	Talk Fri Nov 6 3:05pm–3:25pm Part of Session 106c: Immunosenescence An Actionable, Age-Related Plasma Biomarker Involved in Lung Carcinogenesis 301BC Biomarkers · Tumor biology Session Fri Nov 6 1:45pm–3:25pm Immunosenescence 301BC Tumor biology 1:50pm–2:10pmAging and T-Cell FitnessStanford University 2:10pm–2:30pmSpermidine Improves Anti-Tumor T-Cell Responses by Restoring ER Proteostasis in Aged TILs 2:30pm–2:45pmAbstract presentation — title not yet released 2:45pm–3:05pmHow Age Shapes Breast Cancer Immunity, Therapeutic Response, and OutcomesBrigham and Women's Hospital 3:05pm–3:25pmAn Actionable, Age-Related Plasma Biomarker Involved in Lung CarcinogenesisUniversité Paris Cité
Lausanne University Hospital (CHUV) Lausanne, Switzerland
chuv.ch Cancer centres & hospitals Swiss university hospital affiliated with the University of Lausanne.	Session Fri Nov 6 3:55pm–5:30pm Monitoring and Predicting Responses (AI, radiomics and other modalities) 301A Biomarkers · AI & data 3:55pm–4:35pm2 abstract presentations — titles not yet released
Singapore General Hospital Singapore
sgh.com.sg Cancer centres & hospitals Singapore's largest public hospital and flagship of the SingHealth cluster.	Session Wed Nov 4 3:10pm–3:55pm Panel Discussion 2: Biomarker Discovery and Digital AI Encanto AB Biomarkers · AI & data
Elephas Madison, WI
elephas.com Diagnostics Ex vivo platform that keeps live biopsy tissue intact and measures cytokine responses to predict how a tumor will respond to immunotherapy.	Booth Exhibiting at Booth 1035 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Workshop Sat Nov 7 12:30pm–1:30pm Sponsored Symposium - Elephas 224B
PredxBio Pittsburgh, PA
predxbio.com Software & AI Uses AI on multiomic spatial data to find biomarkers, explain drug mechanisms and predict patient outcomes in cancer.	Booth Exhibiting at Booth 713 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Workshop Fri Nov 6 5:45pm–6:00pm Tech Talk - PredxBio Exhibit Hall Presentation Stage
Quanterix Billerica, MA
quanterix.com Research tools Ultrasensitive protein biomarker company that, after acquiring Akoya Biosciences, also offers high-plex spatial proteomics in tissue.	Booth Exhibiting at Booth 439 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Workshop Fri Nov 6 12:30pm–12:45pm Tech Talk - Quanterix Exhibit Hall Presentation Stage
RareCyte Seattle, WA
rarecyte.com Research tools Makes the Orion spatial proteomics platform for high-plex tissue imaging and CyteFinder liquid biopsy systems for rare cell detection.	Booth Exhibiting at Booth 1020 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Workshop Fri Nov 6 6:45pm–7:00pm Tech Talk - RareCyte Exhibit Hall Presentation Stage Models & tech · Biomarkers
arcoris bio Schlieren, Switzerland
arcorisbio.com Research tools Makes enzyme-free DNA nanotechnology kits that amplify immunofluorescence signal for more sensitive protein and biomarker detection.	Booth Exhibiting at Booth 435 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm
BioLegend San Diego, CA
biolegend.com Research tools Revvity's antibody and reagent brand, supplying flow cytometry, multiomics and biomarker tools for immunology research.	Booth Exhibiting at Booth 623 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm
Caris Life Sciences Irving, TX
carislifesciences.com Diagnostics Molecular profiling company whose tumor testing reads DNA, RNA and proteins, including MSI, tumor mutational load and PD-L1, to guide treatment.	Booth Exhibiting at Booth 515 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm